BlueCrest Capital Management (UK)’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,300	Closed	-$334K	–	635
2014 Q1	$334K	Buy	+7,300	New	+$334K	0.02%	346